Correspondence

This is an unedited manuscript that has been accepted for publication. Nature Research are providing this early version of the manuscript as a service to our customers. The manuscript will undergo copyediting, typesetting and a proof review before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers apply.

Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis

  • Subscribe to Leukemia for full access:

    $1031

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    Rodríguez-Macías G, Martínez-Laperche C, Gayoso J, Noriega V, Serrano D, Balsalobre P, et al. Mutation of the NPM1 gene contributes to the development of donor cell–derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia. Hum Pathol. 2013;44:1696–9.

  2. 2.

    Ribera J-M, Oriol A, Morgades M, Montesinos P, Sarrà J, González-Campos J, et al. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial. J Clin Oncol. 2014;32:1595–604.

  3. 3.

    Hinds DA, Barnholt KE, Mesa RA, Kiefer AK, Do CB, Eriksson N, et al. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood. 2016;128:1121–8.

  4. 4.

    Chen Y, Fang F, Hu Y, Liu Q, Bu D, Tan M, et al. The polymorphisms in LNK gene correlated to the clinical type of myeloproliferative neoplasms. PLoS ONE. 2016;11:e0154183.

  5. 5.

    Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.

  6. 6.

    Advani AS, Lim K, Gibson S, Shadman M, Jin T, Copelan E, et al. OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia. Leuk Lymphoma. 2010;51:606–12.

  7. 7.

    Winum J-Y, Scozzafava A, Montero J-L, Supuran CT. Inhibition of carbonic anhydrase IX: a new strategy against cancer. Anticancer Agents Med Chem. 2009;9:693–702.

  8. 8.

    Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S, et al. A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature. 2011;473:230–3.

  9. 9.

    Grimwade D, Ivey A, Huntly BJP. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood. 2016;127:29–41.

  10. 10.

    Falini B, Martelli MP, Bolli N, Sportoletti P, Liso A, Tiacci E, et al. Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? Blood. 2011;117:1109–20.

  11. 11.

    Patel JL, Schumacher JA, Frizzell K, Sorrells S, Shen W, Clayton A, et al. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia. Leuk Res. 2017;56:7–12.

  12. 12.

    Hollink I, Zwaan CM, Zimmermann M, Arentsen-Peters T, Pieters R, Cloos J, et al. Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia. 2009;23:262–70.

  13. 13.

    Yasuda T, Ueno T, Fukumura K, Yamato A, Ando M, Yamaguchi M, et al. Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation. Leukemia. 2014;28:426–8.

  14. 14.

    Hirsch P, Mamez AC, Belhocine R, Lapusan S, Tang R, Suner L, et al. Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation. Leukemia. 2016;30:1756–9.

  15. 15.

    Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012;366:1090–8.

  16. 16.

    Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21.

  17. 17.

    Engle EK, Fisher DaC, Miller CA, McLellan MD, Fulton RS, Moore DM, et al. Clonal evolution revealed by whole genome sequencing in a case of primary myelofibrosis transformed to secondary acute myeloid leukemia. Leukemia. 2015;29:869–76.

Download references

Acknowledgements

This work was partially supported by the Ministry of Economy and Competitiveness ISCIII-FIS grants PI14/01731, PI17/1880, and RD12/0036/0061, co-financed by ERDF (FEDER) Funds from the European Commission, “A way of making Europe”, as well as grants from the Fundación LAIR, Asociación Madrileña de Hematología y Hemoterapia (AMHH), Asociación Española Contra el Cáncer (AECC), and Fundación Mutua Madrileña (FMM).

Author information

Author notes

    Affiliations

    1. Genomics Unit, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain

      • Julia Suárez-González
      •  & Ismael Buño
    2. Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain

      • Julia Suárez-González
      • , Carolina Martínez-Laperche
      • , Mi Kwon
      • , Pascual Balsalobre
      • , Diego Carbonell
      • , María Chicano
      • , David Serrano
      • , Jorge Gayoso
      • , José Luis Díez-Martín
      •  & Ismael Buño
    3. Department of Hematology, Gregorio Marañón General University Hospital, Madrid, Spain

      • Carolina Martínez-Laperche
      • , Gabriela Rodríguez-Macías
      • , Mi Kwon
      • , Pascual Balsalobre
      • , Diego Carbonell
      • , María Chicano
      • , David Serrano
      • , Jorge Gayoso
      • , José Luis Díez-Martín
      •  & Ismael Buño
    4. Cancer Genomics, IDIVAL, Santander, Spain

      • Nerea Martínez
    5. Sistemas Genómicos, Valencia, Spain

      • Juan Carlos Triviño
    6. Department of Pathology, Fundación Jiménez Díaz, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain

      • Miguel Ángel Piris
    7. Department of Medicine, School of Medicine, Complutense University of Madrid, Madrid, Spain

      • José Luis Díez-Martín

    Authors

    1. Search for Julia Suárez-González in:

    2. Search for Carolina Martínez-Laperche in:

    3. Search for Nerea Martínez in:

    4. Search for Gabriela Rodríguez-Macías in:

    5. Search for Mi Kwon in:

    6. Search for Pascual Balsalobre in:

    7. Search for Diego Carbonell in:

    8. Search for María Chicano in:

    9. Search for David Serrano in:

    10. Search for Juan Carlos Triviño in:

    11. Search for Miguel Ángel Piris in:

    12. Search for Jorge Gayoso in:

    13. Search for José Luis Díez-Martín in:

    14. Search for Ismael Buño in:

    Conflict of interest

    The authors declare that they have no conflict of interest.

    Corresponding author

    Correspondence to Carolina Martínez-Laperche.

    Electronic supplementary material